# Cancer_du_seins
<img width="662" height="465" alt="Screenshot_2025-09-29_20-45-02" src="https://github.com/user-attachments/assets/b1499b77-31dc-4695-9a41-77c58a5e4894" />

<img width="662" height="465" alt="Screenshot_2025-09-29_20-45-38" src="https://github.com/user-attachments/assets/47ccc1ff-20a0-442f-a45d-9109b99935c2" />

<img width="662" height="465" alt="Screenshot_2025-09-29_20-45-54" src="https://github.com/user-attachments/assets/fc1f7b22-eee4-4146-85d5-29fa18952179" />



üß¨ ANALYSE G√âNOMIQUE DU CANCER DU SEIN - DIAGRAMME CTAG
============================================================

üß¨ G√©n√©ration des donn√©es g√©nomiques du cancer du sein...

üëÄ Aper√ßu des donn√©es g√©nomiques:

    Gene  Mutation_Frequency Mutation_Type Clinical_Significance
    BRCA1                0.25    Frameshift            Pathogenic
    BRCA2                0.20      Nonsense            Pathogenic
     TP53                0.35      Missense            Pathogenic
     PTEN                0.08      Deletion            Pathogenic
    PALB2                0.12    Frameshift            Pathogenic
    CHEK2                0.09      Missense            Pathogenic
      ATM                0.07      Missense            Pathogenic
     CDH1                0.08   Splice_Site            Pathogenic

üìä Cr√©ation du diagramme CTAG...

üß¨ RAPPORT D'ANALYSE G√âNOMIQUE - CANCER DU SEIN
============================================================

1. üìä G√àNES LES PLUS MUT√âS:

    ‚Ä¢ TP53: 35.0% (Missense) - Pathogenic

   ‚Ä¢ PIK3CA: 28.0% (Missense) - Oncogenic

   ‚Ä¢ BRCA1: 25.0% (Frameshift) - Pathogenic

   ‚Ä¢ BRCA2: 20.0% (Nonsense) - Pathogenic

   ‚Ä¢ ERBB2: 15.0% (Amplification) - Oncogenic

3. üîç ANALYSE DES G√àNES BRCA:

   ‚Ä¢ BRCA1: Fr√©quence 25.0%

   ‚Ä¢ BRCA2: Fr√©quence 20.0%

5. üíä IMPLICATIONS TH√âRAPEUTIQUES:

   ‚Ä¢ Inhibiteurs de PARP: Indiqu√©s pour mutations BRCA1/2

   ‚Ä¢ Inhibiteurs de PI3K: Pour mutations PIK3CA

   ‚Ä¢ Immunoth√©rapie: Charge mutationnelle √©lev√©e

   ‚Ä¢ Th√©rapies cibl√©es: Bas√©es sur le profil mutationnel

7. üéØ RECOMMANDATIONS DE D√âPISTAGE:

   ‚Ä¢ S√©quen√ßage panel NGS: BRCA1, BRCA2, TP53, PALB2, etc.

   ‚Ä¢ Conseil g√©n√©tique: Pour ant√©c√©dents familiaux

   ‚Ä¢ Surveillance renforc√©e: Porteurs mutations √† haut risque

9. üìà STATISTIQUES GLOBALES:

   ‚Ä¢ Nombre total de g√®nes analys√©s: 14

   ‚Ä¢ Fr√©quence moyenne des mutations: 14.4%

   ‚Ä¢ G√®nes pathog√®nes: 8

   ‚Ä¢ G√®nes oncog√©niques: 6

üî¨ Cr√©ation de l'analyse g√©nomique avanc√©e...

‚úÖ Analyse g√©nomique termin√©e!

üìÅ Fichiers g√©n√©r√©s:

   ‚Ä¢ breast_cancer_ctag_diagram.png
   
   ‚Ä¢ advanced_breast_cancer_genomics.png

# INSTALL DEPENDENCIES 

    pip install -r requirements.txt

# RUN PROGRAM

    chmod +x CSeins.py
    python3 CSeins.py

# EXAMPLE 
<img width="5970" height="4716" alt="breast_cancer_ctag_diagram" src="https://github.com/user-attachments/assets/b84e01bc-0272-4c40-a5c8-e66b3225e961" />


By Gleaphe 2025 .

<img width="5370" height="3539" alt="advanced_breast_cancer_genomics" src="https://github.com/user-attachments/assets/75511a31-8b3e-487e-b21b-bb562656da2a" />



